Literature DB >> 7036277

Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experience.

G Bonadonna, P Valagussa, A Rossi, G Tancini, C Brambilla, S Marchini, U Veronesi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7036277     DOI： 10.1007/978-3-642-81685-7_25

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  6 in total

1.  Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial.

Authors:  J Lacour; F Lacour; A Spira; M Michelson; J Y Petit; G Delage; D Sarrazin; G Contesso; J Viguier
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-25

2.  Adjuvant chemotherapy of breast cancer: hope--reality--hazard?

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1984-02-15

3.  Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy.

Authors:  B Fisher; C K Redmond; D L Wickerham; H E Rockette; A Brown; J Allegra; D Bowman; D Plotkin; J Wolter
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

Review 4.  Drug resistance and cancer chemotherapy strategy in breast cancer.

Authors:  J H Goldie
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

5.  Autologous bone marrow transplantation in metastatic breast cancer.

Authors:  P S Stewart
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

6.  Adjuvant therapy of breast cancer 1971-1981. Ten years of progress.

Authors:  P P Carbone
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.